Related Experiment Videos
Experimental autoimmune uveoretinitis: a model system for immunointervention: a review.
J V Forrester1, J Liversidge, H S Dua
1Department of Opthalmology, University of Aberdeen, Medical School, Foresterhill, UK.
Current Eye Research
|January 1, 1992
Summary
Experimental autoimmune uveoretinitis (EAU) offers insights into human posterior uveitis. This study reviews immuno-therapeutic strategies for EAU, assessing their potential for treating human autoimmune eye diseases.
Area of Science:
- Ophthalmology
- Immunology
- Autoimmune Diseases
Background:
- Experimental autoimmune uveoretinitis (EAU) serves as a key animal model for human posterior uveitis.
- Understanding EAU is crucial for developing effective treatments for autoimmune eye conditions.
Purpose of the Study:
- To provide an overview of current immuno-therapeutic strategies for EAU.
- To evaluate the potential of these strategies for translation to human disease treatment.
Main Methods:
- Review of existing literature on immuno-therapeutic modalities for EAU.
- Analysis of the different stages of EAU amenable to therapeutic intervention (induction, lymphocyte homing, effector phase).
Main Results:
- Identified various immuno-therapeutic approaches targeting different phases of EAU.
- Assessed the applicability and limitations of these strategies for human posterior uveitis.
Conclusions:
- Immuno-intervention in EAU can be targeted at multiple disease stages.
- Further research is needed to optimize and validate EAU-based therapies for human autoimmune uveitis.